Updates

April 8, 2021April 8, 2021
FDA Approval Sought for New Generic Version of Advair Diskus

Lannett is seeking the approval of a generic form of Advair Diskus (fluticasone-salmeterol powder) in the U.S. Such an approval would be expected to ... Read more
April 5, 2021April 5, 2021
Study of Lung Health Among Blacks Earns CHEST Foundation Grant

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) have been awarded a $30,000 CHEST Foundation Research Grant to study racial differences in ... Read more
April 1, 2021April 1, 2021
Long-term Pulmonary Rehabilitation Can Benefit COPD Patients in Real Life

Long-term pulmonary rehabilitation (PR) maintenance programs can benefit people with chronic obstructive pulmonary disease (COPD) in a real-life setting, a retrospective study indicates. In fact, ... Read more
March 29, 2021March 29, 2021
Study Identifies COPD Complications That Increase Patient Risk

Patients with chronic obstructive pulmonary disease who have worse lung function and prior history of acidotic hypercapnic respiratory failure (AHRF) are more likely to develop ... Read more
March 25, 2021March 25, 2021
COPD Foundation, DevPro Biopharma Partner to Boost New Therapy Development

The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma have established a partnership to develop new therapies for people with chronic obstructive pulmonary disease (COPD) and other lung disorders. The ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

June 20, 2017June 20, 2017

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients

News

The effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD) are the target of a new clinical trial that stems from a partnership between medical cannabis products company Tilray and the Research Institute of the McGill University Health ... Read more

Updates

FDA Approval Sought for New Generic Version of Advair Diskus

Study of Lung Health Among Blacks Earns CHEST Foundation Grant

Long-term Pulmonary Rehabilitation Can Benefit COPD Patients in Real Life

Study Identifies COPD Complications That Increase Patient Risk

COPD Foundation, DevPro Biopharma Partner to Boost New Therapy Development

Researchers Find 2 Patterns of Coexisting Disorders in Patients

Viral Infections May Lead to Chronic Lung Disease via Sentinel Immune Cells

Belluscura’s Portable Oxygen Concentrator Cleared for US Market

Researcher Will Use £500,000 Grant to Develop ‘Virtual Lung’

COPD Patients Face Higher Risk of Heart Disorder Ventricular Arrhythmia

Targeted Lung Denervation Found Effective, Safe Over 3 Years of Follow-up

Subscribe to our mailing list

Foundations Merge to Do More for People With Lung Diseases

Partnership Brings Quantitative Imaging Analysis to Diagnosis, Care

FDA OKs Pivotal Trial Testing RheOx System in Chronic Bronchitis

Weight Loss, Low BMI Tied to Worse Mortality in Japanese Men

New Algorithm May Find Misdiagnosis in COPD

Trixeo Aerosphere Approved in Scotland as COPD Maintenance Therapy

American Lung Association Awards $50K for Regenerative Medicine Project

FDA Gives Green Light to Clinical Trial of Zofin

Inhaled Hyaluronan Found to Ease Acute COPD Exacerbations

COPD Foundation, Holy Cross Health Open Program for At-home Care

New Breath Biopsy Panel May Help in COPD Diagnosis

Wellinks’ First Wireless Nebulizer for COPD Cleared for Patient Study

Amoxicillin Alone Better Than Antibiotic Combo for Treating Exacerbations

Noninvasive Home Ventilation Linked to Lower Risk of Death, ER Visits

Study: COPD Treatment in China Relies Too Heavily on Inhaled Corticosteroids

Protein’s Activity Tied to Emphysema, May Link COPD to Lung Cancer

Trixeo Aerosphere Approved in EU for COPD

Inflammatory Biomarkers Distinguish COPD from Asthma-COPD in Some Cases

Partnership Promotes Virtual Pulmonary Rehab Program During Pandemic

American Thoracic Society Publishes New COPD Oxygen Therapy Guidelines

Nuvaira’s Targeted Lung Denervation Therapy Shown to Lower Hospitalization Risk

Wolters Launches Alexa Emmi Care Plan to Enable Close Patient-Clinician Contact

Vaping Linked to Higher Respiratory Disease Risk in Large US Study

Trial Testing RejuvenAir as Chronic Bronchitis Treatment Still Enrolling in Europe

New Therapeutic Target for COPD Identified in Study

Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients